Poultry Farming Applications Animal Parasiticides Market Expansion...

Poultry Farming Applications Animal Parasiticides Market Expansion 2032

Posted 2025-07-01 06:23:24

341

The global animal parasiticides market, valued at US$ 6.2 billion in 2021, is projected to reach US$ 7.9 billion in 2022 and grow at a CAGR of 6.6%, reaching US$ 13.6 billion by 2032. Driven by rising animal health awareness, expanding livestock populations, and technological advancements, the market sees strong demand for ectoparasiticides, which held a 52% share in 2021. North America leads with a 6.5% CAGR, while Asia Pacific grows at 6.2% CAGR, fueled by pet adoption and meat demand. This report analyzes market dynamics, segments, regional insights, and trends through 2032.

For More Insights, Request a Sample of this Report:
https://www.factmr.com/connectus/sample?flag=S&rep_id=4316

Market Analysis

The animal parasiticides market is propelled by increasing zoonotic disease concerns, rising pet ownership, and demand for high-quality animal-derived food. Ectoparasiticides, addressing external parasites like ticks and fleas, dominate with a 52% share and a 6.3% CAGR, driven by their role in preventing human transmission. Innovations like Zoetis’ Simparica TrioTM (FDA-approved in 2020) and Merck’s SPHEREON technology enhance efficacy. Challenges include high product costs and limited rural awareness. Government funding, such as the EU’s US$ 2.2 billion for animal care (2014–2020), and R&D investments support growth.

Segment Analysis

Segmented by product and species, ectoparasiticides (oral tablets, sprays, spot-on) lead with a 6.3% CAGR, followed by endoparasiticides (injectables, feed additives) and endectocides. Companion animals, with US$ 1.8 billion spent in 2021, grow at a 6.1% CAGR, driven by 67% of U.S. households owning pets (APPA data). Food-producing animals, including cattle and poultry, also contribute significantly due to rising meat and dairy demand. Innovations in delivery systems, like Eupraxia’s sustained-release medications, enhance treatment efficacy, boosting market growth across both segments.

Country-wise Insights

North America, led by the U.S. (projected US$ 1.5 billion by 2032, 6.5% CAGR), dominates due to high pet ownership, R&D, and regulations from the USDA’s Animal and Plant Health Inspection Service. Asia Pacific, valued at US$ 3.1 billion by 2026 with a 6.2% CAGR, grows rapidly due to pet adoption and demand for animal byproducts in India (US$ 265 million in 2021) and China. Europe benefits from funding and awareness, while Latin America and MEA are emerging markets driven by improving veterinary infrastructure.

Key Players

Zoetis, Inc.
Merck Animal Health
Ceva Sante Animale
Boehringer Ingelheim GmbH
Elanco Animal Health
Bayer AG
Vetoquinol
Virbac
The Chanelle Group

Strategic Outlook and Industry Trends

Key players focus on R&D and acquisitions, such as Zoetis’ 2022 purchase of NewMetrica for quality-of-life tools and Ceva’s partnership with Mitsui in Japan. Trends include advanced formulations like sustained-release drugs and digital marketing to raise awareness. Rising pet ownership, zoonotic disease concerns, and demand for animal protein drive growth. Regulatory support and direct-to-consumer sales models, as adopted by Zoetis, enhance market reach. Innovations in biologics and sustainable practices will shape the market through 2032.

Segmentation of Animal Parasiticides Market

By Product Type: